Jérôme Michel Claude Fortin
23Patents
4h-index
25Co-inventors
63Inventor score
Filing activity: Aug 29, 2001 → Jun 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9556176B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 29 | Active |
| US8497270B2 | Macrocyclic integrase inhibitors | Chemistry; Metallurgy | 11 | Active |
| US6911444B2 | Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US7449463B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 4 | Expired |
| US8034835B2 | 1-[[2-amino-3-(substituted alkyl)-3H-benzimidazolyl[methyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs | Chemistry; Metallurgy | 3 | Active |
| US10266543B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 2 | Active |
| US6803364B1 | Il-5 inhibiting 6-azauracil derivatives | Chemistry; Metallurgy | 1 | Expired |
| US10280167B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US10280180B2 | Macrocyclic purines for the treatment of viral infections | Chemistry; Metallurgy | 1 | Active |
| US9725432B2 | Pyrimidine derivatives for the treatment of bacterial diseases | Emerging Cross-Sectional Technologies | 1 | Active |
| US7884215B2 | 2-substituted benzimidazoles | Chemistry; Metallurgy | 0 | Active |
| US11795149B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US7956196B2 | 1,3-dihydro-benzimidazol-2-ylidene amines as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US11702426B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
| US10829494B2 | Macrocyclic deaza-purinones for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
| US11312727B1 | Macrocyclic flu endonuclease inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8178694B2 | Heterocyclylaminoalkyl substituted benzimidazoles | Chemistry; Metallurgy | 0 | Active |
| US11407715B2 | Substituted indoline derivatives as dengue viral replication inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10221157B2 | Pyrimidine derivatives for the treatment of bacterial diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US11104678B2 | Purine derivatives for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
| US8883837B2 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US8278455B2 | 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | Chemistry; Metallurgy | 0 | Active |
| US10822349B2 | Macrocyclic purines for the treatment of viral infections | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.